Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4

Molecular Biology of the Cell

Volumn 7, Issue 1, 1996, Pages 57-70

  Guan, Kun Liang ^a   Jenkins, Christopher W ^b   Li, Yan ^b   O'Keefe, Christine L ^c   Noh, Seong ^a   Wu, Xiaoyu ^a   Zariwala, Maimoona ^c   Matera, A Gregory ^c   Xiong, Yue ^b,c,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CDKN2D PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 2D; ENZYME INHIBITOR; MESSENGER RNA; PROTEIN P16INK4A; CELL PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BIOSYNTHESIS; CELL LINE; CHROMOSOME MAP; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; RABBIT; CHROMOSOMAL LOCALIZATION; CHROMOSOME 19P; ENZYME INHIBITION; GENE EXPRESSION; GENE MAPPING; HEMATOPOIETIC CELL; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE; CHROMOSOME MAPPING; CLONING, MOLECULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P19; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; PROTEIN BINDING; RABBITS; RNA, MESSENGER;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0029671263     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.7.1.57     Document Type: Article

References (41)

1. Aprelikova, O., Xiong, Y., and Liu, E.T. (1995). Both p16 and p21 families of CDK inhibitors block CDK phosphorylation by the CDK activating kinase (CAK). J. Biol. Chem. 270, 18195-18197.
2. Baldin, V., Lukas, J., Marcote, M., Pagano, M., and Draetta, G. (1993). Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7, 812-821.
3. ink4. Mol. Cell Biol. 15, 2682-2688.
4. Chen, J., Jackson, P.K., Kirschner, M.W., and Dutta, A. (1995). Separate domains of p21 involved in the inhibition of cdk kinase and PCNA. Nature 374, 386-388.
5. Flores-Rozas, H, Kelman, Z., Dean, F.B., Pan, Z.-Q., Harper, J.W., Elledge, S.J., O'Donell, M., and Hurwitz, J. (1994). Cdk-interacting protein directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase d holoenzyme. Proc. Natl. Acad. Sci. USA 91, 8655-8659.
6. Gu, Y., Turck, C.W., and Morgan, D.O. (1993). Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366, 707-710.
7. Guan, K.-L., and Dixon, J.E. (1991). Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal. Biochem. 192, 262-267.
8. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8, 2939-2952.
9. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 373, 257-261.
10. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K., and Elledge, S.J. (1993). The p21 cdk-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
11. Harper, J.W., Elledge, S.J., Keyomarsi, K., Dynlacht, B., Tsai, L.-H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., Swindell, E., Fox, M.P., and Wei, N. (1995). Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6, 387-400.
12. Hirai, H., Roussel, M.F., Kato, J., Ashmun, R.A., and Sherr, C.J. (1995). Novel INK4 proteins, p19 and p18, are specific inhibitors of cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell Biol. 15, 2672-2681.
13. Hunter, T., and Pines, J. (1994). Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79, 573-582.
14. Huret, J.L., Brizard, A., Slater, R., Charrin, C., Bertheas, M.F., Guilhot, F., Harden, K., Kroes, W., van Leeuwen, E., and School, E.V. (1993). Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical hematological and cytogenetic analyses of 48 patients-updated published cases and 16 new observations. Leukemia 7, 152-160.
15. Jenkins, C.W., and Xiong, Y. (1995). Immunoprecipitation and immunoblotting in cell cycle studies. In Cell Cycle: Material and Methods, ed. M. Pagano, New York: Springer-Verlag, 250-263.
16. Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavitgian, S.V., Stockert, E., Day, R.S., Johnson, B.E., and Skolnick, M.H. (1994). A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436-440.
17. Kato, J., Matsuoka, M., Polyak, K., Massague, J., and Sherr, C.J. (1994a). Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79, 487-496.
18. Kato, J., Matsuoka, M., Strom, D.K., and Sherr, C.J. (1994b). Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14, 2713-2721.
19. Kiechle, S.M., Bauknecht, T., Karck, U., Kommoss, F., du-Bois, A., and Pfleider, A. (1994). Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas. Genes Chromosomes & Cancer 55, 198-205.
20. Koh, J , Enders, G.H., Dynlacht, B.D., and Harlow, E. (1995). Tumor-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375, 506-510.
21. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9, 639-649.
22. Li, Y., Jenkins, C.W., Nichols, M.A., and Xiong, Y. (1994a). Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9, 2261-2268.
23. Li, Y., Nichols, M.A., Shay, J.W., and Xiong, Y. (1994b). Transcriptional repression of the D-type cyclin-dependent kinases inhibitor p16 by the retinoblastoma susceptibility gene product, pRb. Cancer Res. 54, 6078-6082.
24. Lukas, J., Parry, D., Aagaard, L., Mann, D.J., Bartkova, J, Strauss, M., Peters, G., and Bartek, J. (1995). Retinoblastoma-protein-dependent cell cycle inhibition by the tumor suppressor p16. Nature 375, 503-506
25. CIP1. Nature 375, 159-161.
26. Matera, A.G., and Ward, D.C (1992). Oligonucleotide probes for the analysis of specific repetitive DNA sequences by fluorescence in situ hybridization. Human Mol. Genet. 1, 535-539.
27. Kip2, a structurally distinct member of the p21CIP1 CDK inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9, 650-662.
28. Sdi1/CIP1/WAF1. EMBO J. 14, 555-563.
29. Nobori, T., Mlura, K., Wu, D.J., Lois, A., Takabayashi, K., and Carson, D.A. (1994). Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753-756.
30. INK4 in human cancer. Proc. Natl. Acad. Sci. USA 93, 11045-11049.
31. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
32. INK4. Science 267, 249-252.
33. Serrano, M., Hannon, G.J., and Beach, D. (1993). A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707.
34. Sherr, C.J (1994). G1 phase progression: cycling on cue. Cell 79, 551-555.
35. Sherr, C.J., and Roberts, J.M. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
36. Toyoshima, H., and Hunter, T. (1994). p27, a novel inhibitor of C1 cyclin-Cdk proteins kinase activity, is related to p21. Cell 78, 67-74.
37. Waga, S., Hannon, G.J., Beach, D., and Stillman, B. (1994). The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-578.
38. WAF1 and proliferating cell nuclear antigen. Curr. Biol. 5, 275-282.
39. Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993a). p21 is a universal inhibitor of the cyclin kinases. Nature 366, 701-704.
40. Xiong, Y., Zhang, H., and Beach, D. (1992). D-type cyclins associated with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71, 505-514.
41. Xiong, Y., Zhang, H , and Beach, D. (1993b). Subunit rearrangement of cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7, 1572-1583.